Table 1.
N. patients (%) | ||
---|---|---|
Average 2017–2019 |
2020 | |
Total | 374,855 | 405,371 |
Sex | ||
Men | 166,486 (44.4) | 181,583 (44.8) |
Women | 208,369 (55.6) | 223,788 (55.2) |
Age (years) | ||
65–69 | 87,358 (23.3) | 84,279 (20.8) |
70–74 | 88,161 (23.5) | 96,162 (23.7) |
75–79 | 81,982 (21.9) | 78,824 (19.4) |
80–84 | 64,054 (17.1) | 75,154 (18.5) |
≥ 85 | 53,300 (14.2) | 70,952 (17.5) |
Level of complexity | ||
Low | 175,758 (46.9) | 190,222 (46.9) |
Medium | 178,840 (47.7) | 193,274 (47.7) |
High | 20,257 (5.4) | 21,875 (5.4) |
Chronic conditions | ||
Diabetes | 38,334 (10.2) | 41,406 (10.2) |
Respiratory diseases | ||
Asthma | 1500 (0.4) | 1755 (0.4) |
COPD | 10,108 (2.7) | 10,790 (2.7) |
Tumours | ||
Tumours, active | 21,314 (5.7) | 23,192 (5.7) |
Tumours, follow-up | 7079 (1.9) | 7679 (1.9) |
Tumours, remission | 8356 (2.2) | 8956 (2.2) |
Cardiovascular diseases | ||
Ischemic cardiopathy | 27,960 (7.5) | 29,969 (7.4) |
Valvular cardiopathy | 5531 (1.5) | 6123 (1.5) |
Non-arrhythmic myocardiopathy | 13,829 (3.7) | 14,994 (3.7) |
Arrhythmic myocardiopathy | 21,648 (5.8) | 23,202 (5.7) |
Heart failure | 19,831 (5.3) | 21,082 (5.2) |
Arterial vasculopathy | 9756 (2.6) | 10,323 (2.5) |
Cerebral vasculopathy | 13,667 (3.6) | 14,304 (3.5) |
Renal diseases | ||
Chronic renal failure | 8454 (2.3) | 9411 (2.3) |
Liver diseases | ||
Hepatic cirrhosis | 2145 (0.6) | 2302 (0.6) |
Chronic hepatitis | 5513 (1.5) | 6032 (1.5) |
Rheumatoid arthritis | 2534 (0.7) | 3223 (0.8) |
Digestive diseases | ||
Ulcerative colitis/Crohn | 1322 (0.4) | 1474 (0.4) |
Thyroid diseases | ||
Hypothyroidism | 3810 (1.0) | 4649 (1.1) |
Basedow’s disease/hyperthyroidism | 376 (0.1) | 464 (0.1) |
Hashimoto thyroiditis | 745 (0.2) | 934 (0.2) |
COPD chronic obstructive pulmonary disease.